New diabetes clinical trial: A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus Therapy

Published on: 2026-03-11T04:00:00Z
Conditions: Diabetes Mellitus
Interventions: Biological: iPSC-derived islet cell
Sponsors: Peking University First Hospital; Hangzhou Reprogenix Bioscience, Inc
Not yet recruiting
https://ift.tt/zNif1sG